Literature DB >> 17337094

Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus.

Alice Blackshear1, Mihoko Yamamoto, Brenda J Anderson, Philip V Holmes, Linda Lundström, Ulo Langel, John K Robinson.   

Abstract

The neuropeptide galanin and galanin receptors are widespread throughout cortical, limbic and midbrain areas implicated in reward, learning/memory, pain, drinking and feeding. While many studies have shown that galanin produces a variety of presynaptic and post-synaptic responses, work studying the effects of galanin on neural activation is limited. The present study examined patterns of c-Fos immunoreactivity resulting from intracerebroventricular administration of galanin versus saline injection in awake rats. An initial comprehensive qualitative survey was conducted to identify regions of high c-Fos expression followed up with quantitative analysis. Galanin induced a significant increase in c-Fos levels relative to saline-treated controls in dorsomedial hypothalamus and in the central nucleus of the amygdala. This pattern of activation was also produced by galanin receptor type 1 agonist M617. The present findings confirm that galanin upregulates c-Fos activation in hypothalamic nuclei, and supports roles for galanin in central amygdala-mediated regulation of stress-responses, food intake, and Pavlovian conditioning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337094     DOI: 10.1016/j.peptides.2007.01.015

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior.

Authors:  Peng-Hua Fang; Mei Yu; Yin-Ping Ma; Jian Li; Yu-Mei Sui; Ming-Yi Shi
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

Review 2.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

3.  Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test.

Authors:  Zu-In Su; Jennifer Wenzel; Aaron Ettenberg; Osnat Ben-Shahar
Journal:  Addict Biol       Date:  2013-05-01       Impact factor: 4.280

4.  A role of supraspinal galanin in behavioural hyperalgesia in the rat.

Authors:  Diana Amorim; Ana David-Pereira; Patrícia Marques; Sónia Puga; Patrícia Rebelo; Patrício Costa; Antti Pertovaara; Armando Almeida; Filipa Pinto-Ribeiro
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 5.  Galanin's implications for post-stroke improvement.

Authors:  Juhyun Song; Oh Yoen Kim
Journal:  Anat Cell Biol       Date:  2016-12-31

6.  Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats.

Authors:  Zhenwen Zhang; Penghua Fang; Biao He; Lili Guo; Johan Runesson; Ülo Langel; Mingyi Shi; Yan Zhu; Ping Bo
Journal:  J Diabetes Res       Date:  2016-04-05       Impact factor: 4.011

7.  Conformational signatures in β-arrestin2 reveal natural biased agonism at a G-protein-coupled receptor.

Authors:  Arfaxad Reyes-Alcaraz; Yoo-Na Lee; Seongsik Yun; Jong-Ik Hwang; Jae Young Seong
Journal:  Commun Biol       Date:  2018-09-03

8.  Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors.

Authors:  Yoo-Na Lee; Arfaxad Reyes-Alcaraz; Seongsik Yun; Cheol Soon Lee; Jong-Ik Hwang; Jae Young Seong
Journal:  PLoS One       Date:  2020-03-31       Impact factor: 3.240

Review 9.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

Review 10.  Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides.

Authors:  P Marcos; R Coveñas
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.